Translation elongation-3-like factors: Are they rational antifungal targets?

Expert Opinion on Therapeutic Targets

Volumn 6, Issue 5, 2002, Pages 545-553

  Sturtevant, Joy ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Antifungal target; ATP binding cassette (ABC) proteins; EF2; EF3; ELF1; Elongation factors; Fungal translation; NEW1; Prion; Sordarin

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; ANTIFUNGAL AGENT; ELONGATION FACTOR 2; ELONGATION FACTOR 3; FUSIDIC ACID; GM 193663; GM 211676; GM 222712; GM 237354; GR 135402; SORDARIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; FUNGAL CELL; GENE CONSTRUCT; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; NONHUMAN; PHENOTYPE; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TRANSLATION REGULATION;

ANTIFUNGAL AGENTS; CANDIDA; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENE TARGETING; HUMANS; MYCOSES; PEPTIDE ELONGATION FACTOR 1; PEPTIDE ELONGATION FACTORS; PHENOTYPE; PRIONS; SACCHAROMYCES CEREVISIAE; SPECIES SPECIFICITY;

EID: 0036400229     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.6.5.545     Document Type: Review

References (65)

1. MASCHMEYER G: New antifungal agents -treatment standards are beginning to grow old. J. Antimicrob. Chemother. (2002) 49(2):239-241.
2. PRALLER MA: Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. (1996) 22S:89-94.
3. DERAY G: Amphotericin B nephrotoxicity. J. Antimicrob. Chemother. (2002) 49(Suppl. 1):37-41.
4. ELLIS D: Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother. (2002) 49(Suppl. 1):7-10.
5. MCCULLOGH M, HUME S: A longitudinal study of the change in resistance pattern and genetic relationship of oral Candida albicans from HIV-infected patients. J. Med. Vet. Mycol. (1995) 33:33-37.
6. PFALLER MA, RHINE-CHALBERG J, REDDING SW et al.: Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. (1994) 32:59-64.
7. SANGEORZAN JA, BRADLEY SF, HE X et al.: Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment and emergence of fluconazole resistance. Am. J. Med. (1994) 97:339-346.
8. DIEKEMA DJ, MESSER SA, BRUEGGEMANN AB et al.: Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J. Clin. Microbiol. (2002) 40(4):1298-1302.
9. HOPE W, MORTON A, EISEN DP: Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J. Hosp. Infect. (2002) 50(1):56-65.
10. MOSQUERA J, DENNING DW: Azole cross-resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. (2002) 46(2):556-557.
11. VERMES A, GUCHELAAR HJ, DANKERT J: Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J. Antimicrob. Chemother. (2000) 46(2):171-179.
12. DENNING DW: Echinocandins: a new class of antifungal. J. Antimicrob. Chemother. (2002) 49:889-891.
13. GROLL AH, WALSH TJ: Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections. Expert Opin. Investig. Drugs (2001) 10(8):1545-1558.
14. STONE EA, FUNG HB, KIRSCHENBAUM HL: Caspofungin: an echinocandin antifungal agent. Clin. Ther. (2002) 24(3):351-377. Discussion 329.
15. RUBIN MA, CARROLL KC, CAHILL BC: Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans. Clin. Infect. Dis. (2002) 34(8):1160-1161.
16. BELFIELD GP, TUITE MF: Translation elongation factor 3: a fungus-specific translation factor? Mol. Microbiol. (1993) 9(3):411-418.
17. TRIANA-ALONSO FJ, CHAKRABURTTY K, NIERHAUS KH: The elongation factor 3 unique in higher fungi and essential for protein biosynthesis is an E site factor. J. Biol. Chem. (1995) 270(35):20473-20478.
18. SKOGERSON L, ENGELHARDT D: Dissimilarity in protein chain elongation factor requirements between yeast and rat liver ribosomes. Yeast (1977) 14:239-253.
19. QIN SL, XIE AG, BONATO MC, MCLAUGHLIN CS: Sequence analysis of the translational elongation factor 3 from Saccharomyces cerevisiae. J. Biol. Chem. (1990) 265(4):1903-1912.
20. DI DOMENICO BJ, LUPISELLA J, SANDBAKEN M, CHAKRABURTTY K: Isolation and sequence analysis of the gene encoding translation elongation factor 3 from Candida albicans. Yeast (1992) 8(5):337-352.
21. SANDBAKEN MG, LUPISELLA JA, DIDOMENICO B, CHAKRABURTTY K: Protein synthesis in yeast. Structural and functional analysis of the gene encoding elongation factor 3. J. Biol. Chem. (1990) 265(26):15838-15844.
22. YPMA-WONG MF, FONZI WA, SYPHERD PS: Fungus-specific translation elongation factor 3 gene present in Pneumocystis carinii. Infect. Immun. (1992) 60(10):4140-4145.
23. BLAKELY G, HEKMAN J, CHAKRABURTTY K, WILLIAMSON PR: Evolutionary divergence of an elongation factor 3 from Cryptococcus neoformans. J. Bacteriol. (2001) 183(7):2241-2248.
24. URITANI M, SHOUMURA Y, YAMADA S: Detection and analysis of translation elongation factor 3 genes from various yeasts. Biosci. Biotechnol. Biochem. (1999) 63(4):769-772.
25. HIGGINS CF: ABC transporters: from microorganisms to man. Ann. Rev. Cell Biol. (1992) 8:67-113.
26. CHAKRABURTTY K, TRIANO-ALONSO FJ: Yeast elongation factor 3: structure and function. Biol. Chem. (1998) 379(7):831-840.
27. DECOTTIGNIES A, GOFFEAU A: Complete inventory of the yeast ABC proteins. Nat. Genetics (1997) 15:137-145.
28. MAURICE TC, MAZZUCCO CE, RAMANATHAN CS, RYAN BM, WARR GA, PUZISS JW. A highly conserved intraspecies homolog of the Saccharomyces cerevisiae elongation factor-3 encoded by the HEF3 gene. Yeast (1998) 14(12):1105-1113.
29. SARTHY AV, MCGONIGAL T, CAPOBIANCO JO et al.: Identification and kinetic analysis of a functional homolog of elongation factor 3, YEF3, in Saccharomyces cerevisiae. Yeast (1998) 14:239-253.
30. SANTOSO A, CHIEN P, OSHEROVICH LZ, WEISSMAN JS: Molecular basis of a yeast prion species barrier. Cell (2000) 100(2):277-288.
31. KOZAK L, GOPAL G, HO YOON J et al.: Elfp, a member of the ABC class of ATPases, functions as an mRNA export factor in Schizosaccharomyces pombe. J. Biol. Chem. (2002). In press.
32. YUAN DS: Zinc-regulated genes in Saccharomyces cerevisiae revealed by transposon tagging. Genetics (2000) 156(1):45-58.
33. SARTHY AP, MCGONIGAL T, CAPOBIANCO JO et al.: High-level overexpression of yeast elongation factor 3 and detailed kinetic analysis using a coupled spectrophotometric assay. Anal. Biochem. (1997) 254:288-290.
34. HINNEBUSCH AG, NATARAJAN K: Gcn4p, a master regulator of gene expression, is controlled at multiple levels by diverse signals of starvation and stress. Euk. Cell (2002) 1(1):22-32.
35. MARTON MJ, VAZQUEZ DE ALDANA CR, QIU H, CHAKRABURTTY K, HINNEBUSCH AG: Evidence that GCN1 and GCN20, translational regulators of GCN4, function on elongating ribosomes in activation of eIF2α kinase GCN2. Mol. Cell. Biol. (1997) 17:4474-4489.
36. OSHEROVICH LZ, WEISSMAN JS: Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell (2001) 106(2):183-194.
37. Derkatch IL, Bradley ME, Hong JY, Liebman SW. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell (2001) 106(2):171-182.
38. Winzeler EA, Shoemaker DD, Astromoff A et al.: Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 285(5429):901-906.
39. Kinsman OS, Chalk PA, Jackson HC et al.: Isolation and characterisation of an antifungal antibiotic (GR135402) with protein synthesis inhibition. J. Antibiot. (Tokyo) (1997) 51(1):41-49.
40. CAPA L, MENDOZA A, LAVANDERA JL, DE LAS HERAS FG, GARCIA-BUSTOS JF: Translation elongation factor 2 is part of the target for a new family of antifungals. Antimicrob. Agents Chemother. (1998) 42(10):2694-2699.
41. DOMINGUEZ JM, MARTIN JJ: Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans. Antimicrob. Agents Chemother. (1998) 42(9):2279-2283.
42. JUSTICE MC, HSU M-J, TSE B et al.: Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis. J. Biol. Chem. (1998) 273(6):3148-3151.
43. HERREROS E, MARTINEZ CM, ALMELA MJ et al.: Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystic carinii, and filamentous fungi. Antimicrob. Agents Chemother. (1998) 42(11):2863-2869.
44. MENDOZA A, SERRAMIA MJ, CAPA L, GARCIA-BUSTOS JF: Translation elongation factor 2 is encoded by a single essential gene in Candida albicans. Gene (1999) 229:183-191.
45. DOMINGUEZ J, GOMEZ-LORENZO M, MARTIN J: Sordarin inhibits fungal protein synthesis by blocking translocation differently to fusidic acid. J. Biol. Chem. (1999) 274(32):22423-22427.
46. GOMEZ-LORENZO M, GARCIA-BUSTOS JF: Ribosomal P-protein stalk function is targeted by sordarin antifungals. J. Biol. Chem. (1998) 273(39):25041-25044.
47. JUSTICE MC, KU T, HSU MJ, CARNIOL K, SCHMATZ D, NIELSEN J: Mutations in ribosomal protein L10e confer resistance to the fungal-specific eukaryotic elongation factor 2 inhibitor sordarin. J. Biol. Chem. (1999) 274(8):4869-4875.
48. SHASTRY M, NIELSEN J, KU T et al.: Species-specific inhibition of fungal protein synthesis by sordarin: identification of a sordarin-specificity region in eukaryotic elongation factor 2. Microbiol. (2001) 147(Pt 2):383-390.
49. DOMINGUEZ JM, MARTIN J: Identification of a putative sordarin binding site in Candida albicans elongation factor 2 by photoaffinity labeling. J. Biol. Chem. (2001) 276:31402-31407.
50. ARRIBAS EM, CASTRO J, CLEMENS IR et al.: Antifungal sordarins. Synthesis and structure-activity relationships of 3′-O-substituted derivatives. Bioorg. Med. Chem. Lett. (2002) 12(2):117-120.
51. BUENO JM, CUEVAS JC, FIANDOR JM, GARCIA-OCHOA S, GOMEZ DE LAS HERAS F: Antifungal sordarins. Synthesis and structure-activity relationships of 3′,4′-fused dioxolane and dioxane derivatives. Bioorg. Med. Chem. Lett. (2002) 12(2):121-124.
52. KANEKO S, UCHIDA T, SHIBUYA S et al.: Synthesis of Sordaricin analogues as potent antifungal agents against Candida albicans. Bioorg. Med. Chem. Lett. (2002) 12(5):803-806.
53. STURTEVANT J, CIHLAR RL, CALDERONE RA: Disruption studies of a Candida albicans gene, ELF1 a member of the ATP binding cassette family. Microbiology (1998) 144(8):2311-2321.
54. ROZWADOWSKI TJ: Elongation like factor 1: a new pharmacological target in Candida albicans. Undergraduate Thesis prepared for Department of Biology, Georgetown University, Washington DC, USA(2001):1-53.
55. CALDERONE RA, FONZI WA: Virulence factors of Candida albicans. Trends Microbiol. (2001) 9(7):327-335.
56. ENLOE B, DIAMOND A, MITCHELL AP: A single-transformation gene function test in diploid Candida albicans. J. Bacteriol. (2000) 182(20):5730-5736.
57. MUHLRAD D, HUNTER R, PARKER R: A rapid method for localized mutagenesis of yeast genes. Yeast (1992) 8(2):79-82.
58. TUITE MF: Yeast prions and their prion-forming domain. Cell (2000) 100(3):289-292.
59. OSHEROVICH LZ, WEISSMAN JS: The utility of prions. Dev. Cell (2002) 2(2):143-151
60. PRUSINER SB: Prions. Proc. Natl. Acad. Sci. USA (1998) 95(23):13363-13383.
61. WICKNER RB, EDSKES HK, ROBERTS BT, PIERCE MM, BAXA U, ROSS E: Prions beget prions: the [PIN+] mystery! Trends Biochem. Sci. (2001) 26(12):697-699.
62. RESENDE C, PARHAM SN, TINSLEY C, FERREIRA P, DUARTE JA, TUITE MF: The Candida albicans Sup35p protein (CaSup35p): function, prion-like behaviour and an associated polyglutamine length polymorphism. Microbiology (2002) 148(Pt 4):1049-1060.
63. WICKNER RB, EDSKES HK, MADDELEIN ML, TAYLOR KL, MORIYAMA H: Prions of yeast and fungi. Proteins as genetic material. J. Biol. Chem. (1999) 274(2):555-558.
64. WICKNER RB, EDSKES HK, ROBERTS BT, PIERCE M, BAXA U: Prions of yeast as epigenetic phenomena: high protein 'copy number' inducing protein 'silencing'. Adv. Genet. (2002) 46:485-525.
65. DOMINGUEZ JM, KELLY VA, KINSMAN OS, MARRIOTT MS, GOMES DE LAS HERAS F, MARIN JJ: Sordarins: a new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts. Antimicrob. Agents Chemother. (1998) 42(9):2274-2278.